Home > Healthcare > Medical Devices > Therapeutic Devices > Particle Therapy Market

Particle Therapy Market Trends

Report ID: GMI6604
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Particle Therapy Market Trends

Growing global burden of cancer is expected to boost the market growth. For instance, according to the American Cancer Society report, in 2022, there were an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S. alone. As cancer cases continue to increase worldwide, the demand for innovative and effective treatment alternatives has become increasingly urgent. Particle therapy, known for its remarkable precision in targeting cancer cells while minimizing harm to healthy tissue, emerges as a compelling solution. Furthermore, particle therapy's ability to deliver highly focused radiation directly to the tumour site enhances the potential for successful outcomes and reduced collateral damage, thereby escalate the global market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for particle therapy was valued at USD 837.09 million in 2022 and will register 8.8% CAGR from 2024-2032 due to the growing global burden of cancer.

The proton therapy type segment recorded 72.7% share of the particle therapy industry in 2022 and will witness significant growth from 2023-2032 on account of its effectiveness in treating pediatric cancers and intricate tumors.

North America recorded 46% share of the particle therapy industry in 2022 and is expected to register significant CAGR from 2023-2032 owing to the presence of robust research and development landscape coupled with substantial investments in healthcare innovation in the region.

Danfysik A/S, Hitachi, Ltd., IBA, Mevion Medical Systems, and Optivus Proton Therapy, Inc. are some of the major particle therapy companies worldwide.